K Number
K071377

Validate with FDA (Live)

Device Name
POLARIS BE RODS
Manufacturer
Date Cleared
2007-08-06

(81 days)

Product Code
Regulation Number
888.3050
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The SYNERGY Spinal System implants are intended to be used as a temporary construct that assists normal healing and are not intended to replace normal body structures. They are intended to stabilize the spinal operative site during fusion procedures and should be removed after fusion.

The implants are attached to the spine posteriorly by means of hooks and/or screws joined with rods and anteriorly by means of vertebral screws joined with rods.

As a pedicle screw system the SYNERGY Spinal System is intended only for patients: (a) having severe spondylolisthesis (Grades 3 and 4) of the fifth lumbar-first sacral (L5-S1) vertebral joint; (b) who are receiving fusions using autogenous bone graft only; (c) who are having the screws fixed or attached to the lumbar and sacral spine; and (d) who are having the device removed after the development of a solid fusion mass. The levels of screw fixation are L3 to S1/Ilium.

In addition, the pedicle screw system may also be used to provide immobilization and stabilization of spinal segments, in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis).

As a posterior, non-pedicle, screw and hook system, and an anterolateral, intervertebral body screw system, the specific indications for the SYNERGY Spinal System are:

  1. Degenerative Disc Disease (as defined by chronic back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies).
  2. Idiopathic scoliosis.
  3. Kyphotic deformities of the spine.
  4. Paralytic scoliosis and/or pelvic obliquity.
  5. Lordotic deformities of the spine.
  6. Neuromuscular scoliosis associated with pelvic obliquity.
  7. Vertebral fracture or dislocation.
  8. Tumors.
  9. Spondylolisthesis.
  10. Stenosis.
  11. Pseudarthrosis.
  12. Unsuccessful previous attempts at spinal fusion.

For posterior, non-pedicle, screw use, the SYNERGY screws and lateral connectors are intended for sacral/iliac attachment only, and the SYNERGY hooks and transverse connectors are intended for posterior thoracic and/or lumbar use only. As a whole, the levels of use are T1 to the Sacrum/Ilium.

The Bullet End Rods are intended for use with the Jackson Intrasacral Fixation Technique.

The Adjustable Length Rod is intended for in situ adjustment after placement of the hooks or screws during spinal fusion surgery.

For anterior use, the recommended levels of attachment are: T10 to L3 for the double rod constructs and T5 to L5 for the single rod constructs. The 4.75 mm diameter rod system can be used in single and double rod constructs while the 6.35 mm diameter rod system is to only be used in single rod constructs. In all cases, instrumentation must be at least 1 cm from any major vessel.

Device Description

The Polaris™ BE Rods are manufactured from CP titanium or stainless steel in a diameter of 6.35mm. Two styles of rods are available, double bullet-ended and single bullet-ended where the opposite end is blunt like standard rods. This tip design facilitates the use of an intrasacral surgical technique (Jackson Intrasacral Fixation Technique). Lengths vary from 6 to 60cm.

AI/ML Overview

This submission is for Polaris™ BE Rods, which are spinal rods made from CP titanium or stainless steel, designed for use in spinal fusion procedures. The submission states that "No clinical testing is necessary for a determination of substantial equivalence." Therefore, there is no study that proves the device meets acceptance criteria.

The following information is what can be extracted from the provided text based on your request, even though the core request regarding acceptance criteria and a proving study is not met by the document.

1. Table of Acceptance Criteria and Reported Device Performance

Not applicable. The submission explicitly states "No clinical testing is necessary for a determination of substantial equivalence." The device is deemed substantially equivalent based on similarities in materials, design, sizing, and indications to predicate devices. There are no explicitly defined acceptance criteria or performance metrics reported from a study within this document.

2. Sample Size Used for the Test Set and Data Provenance

Not applicable. No dedicated test set was used for a study proving acceptance criteria. A paper containing retrospective outcome data for intrasacral rod fixation is mentioned as provided, but details about the sample size, country of origin, or how it relates to proving acceptance criteria for this specific device are not given. This paper is presented as supplementary information rather than a primary study demonstrating performance against acceptance criteria for the Polaris™ BE Rods.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts

Not applicable. No ground truth establishment by experts for a test set is described, as no such study was conducted for this device's substantial equivalence determination.

4. Adjudication Method for the Test Set

Not applicable. No adjudication method is mentioned as no test set was used for a study proving acceptance criteria for this device.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

Not applicable. This device is a physical spinal rod, not an AI-assisted diagnostic or therapeutic tool. Therefore, an MRMC comparative effectiveness study with or without AI assistance is irrelevant and not mentioned.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Not applicable. This device is a physical spinal rod, not an algorithm.

7. The Type of Ground Truth Used

Not applicable. No ground truth type is specified, as no study requiring ground truth establishment was conducted for this device. The basis for approval is substantial equivalence to predicate devices, focusing on materials, design, sizing, and indications.

8. The Sample Size for the Training Set

Not applicable. There is no training set mentioned, as this device does not involve machine learning or AI.

9. How the Ground Truth for the Training Set Was Established

Not applicable. As there is no training set, there is no mention of how ground truth for it was established.

{0}------------------------------------------------

K07/377

AUG -6 2007

Section 5: 510(k) Summary

  • Auqust 1, 2007 Preparation Date:
    Applicant/Sponsor: Biomet Spine (formally EBI Spine) 100 Interpace Parkway Parsippany, NJ 07054

  • Contact Person: Debra Bing Director of Regulatory Affairs Biomet Spine

  • Polaris™ BE Rods Proprietary Name:

  • Common Name: Spinal Rods

  • Classification Name: Application, Fixation, Spinal Interlaminal (87 KWP) Orthosis, Spinal Pedicle Fixation (MNI) Orthosis, Spondylosthesis Spinal Fixation (MNH) Orthosis, Spinal Pedicle Fixation, for Degenerative Disc Disc Disease (NKB)

Legally Marketed Devices To Which Substantial Equivalence Is Claimed:

Synerqy™ Spinal System (Interpore Cross, Inc.*) K940631

Synerqy™ Ti Posterior Spinal System (Interpore Cross, Inc. * ) K950099

Device Description: The Polaris™ BE Rods are manufactured from CP titanium or stainless steel in a diameter of 6.35mm. Two styles of rods are available, double bullet-ended and single bullet-ended where the opposite end is blunt like standard rods. This tip design facilitates the use of an intrasacral surgical technique (Jackson Intrasacral Fixation Technique). Lengths vary from 6 to 60cm.

* Interpore Cross, Inc. is now a Biomet Company

{1}------------------------------------------------

Intended Use:

INDICATIONS-FOR-USE

The SYNERGY Spinal System implants are intended to be used as a temporary construct that assists normal healing and are not intended to replace normal body structures. They are intended to stabilize the spinal operative site during fusion procedures and should be removed after fusion.

The implants are attached to the spine posteriorly by means of hooks and/or screws joined with rods and anteriorly by means of vertebral screws joined with rods.

As a pedicle screw system the SYNERGY Spinal System is intended only for patients: (a) having severe spondylolisthesis (Grades 3 and 4) of the fifth lumbar-first sacral (L5-S1) vertebral joint; (b) who are receiving fusions using autogenous bone graft only; (c) who are having the screws fixed or attached to the lumbar and sacral spine; and (d) who are having the device removed after the development of a solid fusion mass. The levels of screw fixation are L3 to S1/Ilium.

In addition, the pedicle screw system may also be used to provide immobilization and stabilization of spinal segments, in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis).

As a posterior, non-pedicle, screw and hook system, and an anterolateral, intervertebral body screw system, the specific indications for the SYNERGY Spinal System are:

    1. Degenerative Disc Disease (as defined by chronic back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies).
    1. Idiopathic scoliosis.
    1. Kyphotic deformities of the spine.
    1. Paralytic scoliosis and/or pelvic obliquity.
    1. Lordotic deformities of the spine.
    1. Neuromuscular scoliosis associated with pelvic obliquity.
    1. Vertebral fracture or dislocation.
    1. Tumors.

{2}------------------------------------------------

    1. Spondylolisthesis.
    1. Stenosis.
    1. Pseudarthrosis.
    1. Unsuccessful previous attempts at spinal fusion.

For posterior, non-pedicle, screw use, the SYNERGY screws and lateral connectors are intended for sacral/iliac attachment only, and the SYNERGY hooks and transverse connectors are intended for posterior thoracic and/or lumbar use only. As a whole, the levels of use are T1 to the Sacrum/Ilium.

The Bullet End Rods are intended for use with the Jackson Intrasacral Fixation Technique.

The Adjustable Length Rod is intended for in situ adjustment after placement of the hooks or screws during spinal fusion surgery.

For anterior use, the recommended levels of attachment are: T10 to L3 for the double rod constructs and T5 to L5 for the single rod constructs. The 4.75 mm diameter rod system can be used in single and double rod constructs while the 6.35 mm diameter rod system is to only be used in single rod constructs. In all cases, instrumentation must be at least 1 cm from any major vessel.

Summary of Technologies: The technological characteristics (materials, design, sizing, indications) of the Polaris™ BE Rods are similar to or identical to the predicate devices.

Non-Clinical Testing: Because the Polaris™ BE Rods are identical in material, diameter and minimum and maximum length, they can be expected to perform mechanically in the same manner as the predicates. An engineering rationale is provided.

Clinical Testing: No clinical testing is necessary for a determination of substantial equivalence. However, a paper containing retrospective outcome data for intrasacral rod fixation is provided.

All trademarks are property of Biomet, Inc.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG -6 2007

Biomet Spine (Former EBI Spine) % Ms. Debra Bing Director of Regulatory Affairs 100 Interpace Parkway Parsippany, NJ 07054

Re: K071377

Trade/Device Name: Polaris™ BE Rods Regulation Number; 21 CFR 888.3070 Regulation Name: Pedicle screw spinal system Regulatory Class: III Product Code: NKB, KWP, MNI, MNH Dated: May 16, 2007 Received: May 17, 2007

Dear: Ms. Debra Bing:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Ilisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{4}------------------------------------------------

Page 2 - Ms. Debra Bing

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,
Mark A. Millman

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

510(k) Number (if known): K071377

Device Name: Polaris™ BE Rods

INDICATIONS-FOR-USE

The SYNERGY Spinal System implants are intended to be used as a temporary construct that assists normal healing and are not intended to replace normal body structures. They are intended to stabilize the spinal operative site during fusion procedures and should be removed after fusion,

The implants are attached to the spine posteriorly by means of hooks and/or screws joined with rods and anteriorly by means of vertebral screws joined with rods.

As a pedicle screw system the SYNERGY Spinal System is intended only for patients: (a) having severe spondylolisthesis (Grades 3 and 4) of the fifth lumbar-first sacral (L5-S1) vertebral joint; (b) who are receiving fusions using autogenous bone graft only; (c) who are having the screws fixed or attached to the lumbar and sacral spine; and (d) who are having the device removed after the development of a solid fusion mass. The levels of screw fixation are L3 to S1/Illium.

In addition, the pedicle screw system may also be used to provide immobilization and stabilization of spinal segments, in skeletally mature patients as an adjunct to fusion in the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis).

As a posterior, non-pedicle, screw and hook system, and an anterolateral, intervertebral body screw system, the specific indications for the SYNERGY Spinal System are:

    1. Degenerative Disc Disease (as defined by chronic back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies).
  • Idiopathic scoliosis. 2.
    1. Kyphotic deformities of the spine.
    1. Paralytic scoliosis and/or pelvic obliquity.
    1. Lordotic deformities of the spine.
  • Neuromuscular scoliosis associated with pelvic obliquity. ଚି.
    1. Vertebral fracture or dislocation.
    1. Tumors.
    1. Spondylolisthesis.
    1. Stenosis.
    1. Pseudarthrosis.
    1. Unsuccessful previous attempts at spinal fusion.
Prescription Use(Part 21 CFR 801 Subpart D)X
----------------------------------------------------

AND/OR

Over-The-Counter Use(21 CFR 807 Subpart C)NO
----------------------------------------------------

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)Concurrence of CDRH, Office of Device Evaluation (ODE)

Mark N. Milliron

(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices

510(k) Number

Page 1 of 2

{6}------------------------------------------------

K071377 Indications for Use (continued)

For posterior, non-pedicle, screw use, the SYNERGY screws and lateral connectors are intended for sacral/iliac attachment only, and the SYNERGY hooks and transverse connectors are intended for posterior thoracic and/or lumbar use only. As a whole, the levels of use are T1 to the Sacrum/Illium.

The Bullet End Rods are intended for use with the Jackson Intrasacral Fixation Technique.

The Adjustable Length Rod is intended for in situ adjustment of the hooks or screws during spinal fusion surgery.

For anterior use, the recommended levels of attachment are: T10 to L3 for the double rod constructs and T5 to L5 for the single rod constructs. The 4.75 mm diameter rod system can be used in single and double rod constructs while the 6.35 mm diameter rod system is to only be used in single rod constructs. In all cases, instrumentation must be at least 1 cm from any major vessel.

Prescription Use _ × AND/OR Over-The-Counter Use _ NO (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Mark N. Wilkerson

510(k) Number_

§ 888.3050 Spinal interlaminal fixation orthosis.

(a)
Identification. A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome.(b)
Classification. Class II.